Hendrik Milting

Title: Hendrik Milting: Innovator in Biomarker Research

Introduction

Hendrik Milting is a notable inventor based in Bad Oeynhausen, Germany. He has made significant contributions to the field of biomarker research, particularly in relation to various diseases. His work focuses on the identification and application of biomarkers that can aid in the diagnosis and treatment of serious health conditions.

Latest Patents

Hendrik Milting holds a patent for LTBP2 as a biomarker and diagnostic target. This invention provides LTBP2, which is associated with cardiovascular diseases, hematological diseases, neurological diseases, cancer, endocrinological diseases, and urological diseases. The patent also includes assays for identifying compounds useful in the treatment or prevention of these diseases. Furthermore, it features compounds that bind to and/or activate or inhibit the activity of LTBP2, along with pharmaceutical compositions comprising such compounds. LTBP2 is presented as a valuable biomarker for a range of diseases, enhancing the potential for targeted therapies.

Career Highlights

Throughout his career, Hendrik Milting has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Schering Pharma AG and Bayer Intellectual Property GmbH. His experience in these organizations has contributed to his expertise in biomarker research and development.

Collaborations

Hendrik Milting has collaborated with notable professionals in his field, including Stefan Golz and Holger Summer. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Hendrik Milting's work in biomarker research, particularly with LTBP2, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the diagnosis and treatment of various diseases.